The DOI matches its Crossref record; 304 of the 305 references it cites were found in a registry or an index.
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary
Open accessAbstract
This Executive Summary of the Global Strategy for the Diagnosis, Management, and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 report focuses primarily on the revised and novel parts of the document. The most significant changes include: (1) the assessment of chronic obstructive pulmonary disease has been refined to separate the spirometric assessment from symptom evaluation. ABCD groups are now proposed to be derived exclusively from patient symptoms and their history of exacerbations; (2) for each of the groups A to D, escalation strategies for pharmacologic treatments are proposed; (3) the concept of deescalation of therapy is introduced in the treatment assessment scheme; (4) nonpharmacologic therapies are comprehensively presented; and (5) the importance of comorbid conditions in managing chronic obstructive pulmonary disease is reviewed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The current treatment strategy for COPD includes inhaled corticosteroids, anticholinergics, and β2-agonists, which have been primarily effective in controlling the symptoms but do not cure the underlying disease.184”
From Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles (2019) · cites this paper as [184]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
The National Lung Screening Trial Research Team (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102873 · Cited by 11,064
Celli, B. R., MacNee, W., Agustí, A. G. N., Anzueto, A. R., Berg, B., Buist, A. S., Calverley, P. M., Chavannes, N. H., Dillard, T. A., Fahy, B. F., et al. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00014304 · Cited by 4,410
Self-citationCelli, B. R., Cote, C. G., Marin, J. M., Casanova, C., Montes de Oca, M., Mendez, R. A., Pinto Plata, V., & Cabral, H. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa021322 · Cited by 4,015
Self-citationSpruit, M. A., Singh, S. J., Garvey, C., ZuWallack, R., Nici, L., Rochester, C., Hill, K., Holland, A. E., Lareau, S. C., Man, W. D.-C., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201309-1634st · Cited by 3,938
Self-citationSalmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
CALVERLEY, P. M. A., Anderson, J. A., Celli, B. R., Ferguson, G. T., Jenkins, C. R., Jones, P., Yates, J., & Vestbo, J. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063070 · Cited by 3,234
Self-citationJones, P. W., Quirk, F. H., Baveystock, C. M., & Littlejohns, P. (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/145.6.1321 · Cited by 3,035
Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease
Hurst, J. R., Vestbo, J., Anzueto, A. R., Locantore, N., Müllerová, H., Tal‐Singer, R., Miller, B. E., Lomas, D. A., Agustí, A. G. N., MacNee, W., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909883 · Cited by 2,983
Self-citationBestall, J. C., Paul, E. A., Garrod, R., Garnham, R., Jones, P. W., & Wedzicha, J. A. (1999) · Thorax · doi:10.1136/thx.54.7.581 · Cited by 2,927
Self-citationAntibiotic Therapy in Exacerbations of Chronic Obstructive Pulmonary Disease
Anthonisen, N. R., MANFREDA, J., WARREN, C. P. W., HERSHFIELD, E. S., HARDING, G. K. M., & NELSON, N. A. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-2-196 · Cited by 2,474
Buist, A. S., McBurnie, M. A., Vollmer, W. M., Gillespie, S., Burney, P., Mannino, D. M., Menezes, A. M., Sullivan, S. D., Lee, T. A., Weiss, K. B., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61377-4 · Cited by 2,364
Research works printed but not linked: 34
- Medical Research Council Committee on the Aetiology of Chronic Bronchitis, 1965, Definition and classification of chronic bronchitis for clinical and epidemiological purposes: a report to the Medical Research Council by their Committee on the Aetiology of Chronic Bronchitis, Lancet, 1, 775
- Fletcher, 1960, Standardised questionnaire on respiratory symptoms: a statement prepared and approved by the MRC Committee on the Aetiology of Chronic Bronchitis (MRC breathlessness score), BMJ, 2, 1662
- National Institute for Health and Care Excellence, 2016, Multimorbidity: clinical assessment and management, in press
- 1997, Alpha 1-antitrypsin deficiency: memorandum from a WHO meeting, Bull World Health Organ, 75, 397
- van Eerd, 2016, Smoking cessation for people with chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD010744
- van der Meer, 2003, Smoking cessation for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD002999
- McNeill, 2015, E-cigarettes: an evidence update
- McRobbie, 2014, Electronic cigarettes for smoking cessation and reduction, Cochrane Database Syst Rev, 12, CD010216
- Cahill, 2013, Pharmacological interventions for smoking cessation: an overview and network meta-analysis, Cochrane Database Syst Rev, 5, CD009329
- Stead, 2013, Physician advice for smoking cessation, Cochrane Database Syst Rev, 5, CD000165
- Stead, 2016, Combined pharmacotherapy and behavioural interventions for smoking cessation, Cochrane Database Syst Rev, 3, CD008286
- Poole, 2006, Influenza vaccine for patients with chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD002733
- Wongsurakiat, 2003, Economic evaluation of influenza vaccination in Thai chronic obstructive pulmonary disease patients, J Med Assoc Thai, 86, 497
- Fiore, 2009, Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009, MMWR Recomm Rep, 58, 1
- Appleton, 2006, Ipratropium bromide versus long-acting beta-2 agonists for stable chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD006101
- Karner, 2014, Tiotropium versus placebo for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 7, CD009285
- Ram, 2002, Oral theophylline for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD003902
- Nannini, 2012, Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 9, CD006829
- Nannini, 2013, Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 8, CD006826
- Yang, 2012, Inhaled corticosteroids for stable chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 7, CD002991
- Chong, 2013, Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 11, CD002309
- Poole, 2015, Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD001287
- Puhan, 2011, Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD005305
- Kruis, 2013, Integrated disease management interventions for patients with chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 10, CD009437
- Halpin, 2009, Palliative and end-of-life care for patients with respiratory diseases, Eur Respir Monograph, 43, 327
- Cranston, 2005, Domiciliary oxygen for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD001744
- Barr, 2005, Inhaled tiotropium for stable chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD002876
- Karner, 2012, Long-acting beta(2)-agonist in addition to tiotropium versus either tiotropium or long-acting beta(2)-agonist alone for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 4, CD008989
- Tomczyk, 2014, Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP), MMWR Morb Mortal Wkly Rep, 63, 822
- Tiong, 2006, Lung volume reduction surgery for diffuse emphysema, Cochrane Database Syst Rev, CD001001
- Vollenweider, 2012, Antibiotics for exacerbations of chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 12, CD010257
- Ram, 2006, Antibiotics for exacerbations of chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD004403
- Schuetz, 2012, Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections, Cochrane Database Syst Rev, CD007498
- Bradley, 1985, Role of daytime hypoxemia in the pathogenesis of right heart failure in the obstructive sleep apnea syndrome, Am Rev Respir Dis, 131, 835
Cited by
Sorted by citations
Items 101–200 of 1,001
Chen, H., Oliver, B. G. G., Pant, A., Olivera, A., Poronnik, P., Pollock, C. A., & Saad, S. (2022) · Environmental Research · doi:10.1016/j.envres.2022.113378 · Cited by 119
Physical activity and chronic obstructive pulmonary disease: a scoping review
Xiang, X., Huang, L., Fang, Y., Cai, S., & Zhang, M. (2022) · BMC Pulmonary Medicine · doi:10.1186/s12890-022-02099-4 · Cited by 115
A Review of Chronic Comorbidities in Adults Living With HIV: State of the Science
Webel, A. R., Schexnayder, J. K., Cioe, P. A., & Zuniga, J. A. (2021) · Journal of the Association of Nurses in AIDS Care · doi:10.1097/jnc.0000000000000240 · Cited by 109
Metformin: Experimental and Clinical Evidence for a Potential Role in Emphysema Treatment
Polverino, F., Wu, T. D., Rojas-Quintero, J., Wang, X., Mayo, J., Tomchaney, M., Tram, J., Packard, S., Zhang, D., Cleveland, K. H., et al. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202012-4510oc · Cited by 100
Self-citationWan, E. S., Kantorowski, A., Homsy, D., Teylan, M., Kadri, R., Richardson, C. R., GAGNON, D. R., Garshick, E., & Moy, M. L. (2017) · Respiratory Medicine · doi:10.1016/j.rmed.2017.07.057 · Cited by 100
Diffusing Capacity of Carbon Monoxide in Assessment of COPD
Balasubramanian, A., MacIntyre, N. R., Henderson, R. J., Jensen, R. L., Kinney, G., Stringer, W. W., Hersh, C. P., Bowler, R. P., Casaburi, R., Han, M. K., et al. (2019) · Chest · doi:10.1016/j.chest.2019.06.035 · Cited by 100
Canepa, M., Franssen, F. M. E., Olschewski, H., Lainščak, M., Böhm, M., Tavazzi, L., & Rosenkranz, S. (2019) · JACC Heart Failure · doi:10.1016/j.jchf.2019.05.009 · Cited by 100
Rittayamai, N., Phuangchoei, P., Tscheikuna, J., Praphruetkit, N., & Brochard, L. J. (2019) · Annals of Intensive Care · doi:10.1186/s13613-019-0597-5 · Cited by 105
PM2.5 induces pulmonary microvascular injury in COPD via METTL16-mediated m6A modification
Guo, X., Lin, Y., Lin, Y., Zhong, Y., Yu, H., Huang, Y., Yang, J., Cai, Y., Liu, F., Li, Y., et al. (2022) · Environmental Pollution · doi:10.1016/j.envpol.2022.119115 · Cited by 99
Respiratory Symptoms in Young Adults and Future Lung Disease. The CARDIA Lung Study
Kalhan, R., Dransfield, M. T., Colangelo, L. A., Cuttica, M. J., Jacobs, D. R., Thyagarajan, B., Estépar, R. S. J., Harmouche, R., Onieva, J. O., Ash, S. Y., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201710-2108oc · Cited by 98
Tomašić, I., Tomašić, N., Trobec, R., Krpan, M., & Kelava, T. (2018) · Medical & Biological Engineering & Computing · doi:10.1007/s11517-018-1798-z · Cited by 100
Metabolomic Pattern Predicts Incident Coronary Heart Disease
Wang, Z., Zhu, C., Nambi, V., Morrison, A. C., Folsom, A. R., Ballantyne, C. M., Boerwinkle, E., & Yu, B. (2019) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.312236 · Cited by 96
The Oral-Lung Axis: The Impact of Oral Health on Lung Health
Gaeckle, N. T., Pragman, A. A., Pendleton, K. M., Baldomero, A. K., & Criner, G. J. (2020) · Respiratory Care · doi:10.4187/respcare.07332 · Cited by 98
Self-citationII Consenso Brasileiro em Paracoccidioidomicose - 2017*
Shikanai‐Yasuda, M. A., Mendes, R. P., Colombo, A. L., Telles, F. D. Q., Kono, A., Paniago, A. M. M., Nathan, A., Francesconi-do-Valle, A. C., Bagagli, E., Benard, G., et al. (2018) · Epidemiologia e Serviços de Saúde · doi:10.5123/s1679-49742018000500001 · Cited by 94
Iron Homeostasis in the Lungs—A Balance between Health and Disease
Neves, J., Haider, T., Gassmann, M., & Muckenthaler, M. U. (2019) · Pharmaceuticals · doi:10.3390/ph12010005 · Cited by 94
Brassington, K., Selemidis, S., Bozinovski, S., & Vlahos, R. (2019) · Clinical Science · doi:10.1042/cs20180316 · Cited by 97
The Role of Palliative Care in COPD
Iyer, A. S., Sullivan, D. R., Lindell, K. O., & Reinke, L. F. (2021) · CHEST Journal · doi:10.1016/j.chest.2021.10.032 · Cited by 96
Precision medicine in COPD: where are we and where do we need to go?
Sidhaye, V. K., Nishida, K. S., & Martínez, F. J. (2018) · European Respiratory Review · doi:10.1183/16000617.0022-2018 · Cited by 94
Abdulai, R. M., Jensen, T. J., Patel, N. R., Polkey, M. I., Jansson, P., Celli, B. R., & Rennard, S. I. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201703-0615ci · Cited by 95
Self-citationVoxel-Wise Longitudinal Parametric Response Mapping Analysis of Chest Computed Tomography in Smokers
Labaki, W. W., Gu, T., Murray, S., Hatt, C. R., Galbán, C. J., Ross, B. D., Martinez, C. H., Curtis, J. L., Hoffman, E. A., Pompe, E., et al. (2018) · Academic Radiology · doi:10.1016/j.acra.2018.05.024 · Cited by 92
High flow through nasal cannula in exacerbated COPD patients: a systematic review
Pisani, L., Astuto, M., Prediletto, I., & Longhini, F. (2019) · Pulmonology · doi:10.1016/j.pulmoe.2019.08.001 · Cited by 92
Mohamed, A. A., Kunda, N. K., Ross, K., Hutcheon, G. A., & Saleem, I. Y. (2019) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2019.01.002 · Cited by 92
Cillóniz, C., Ferrer, M., Liapikou, A., García‐Vidal, C., Gabarrús, A., Ceccato, A., de la Bellacasa, J. P., Blasi, F., & Torres, A. (2018) · European Respiratory Journal · doi:10.1183/13993003.02215-2017 · Cited by 92
Yu, D., Liu, X., Zhang, G., Ming, Z., & Wang, T. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01001 · Cited by 90
Eapen, M. S., Hansbro, P. M., Larsson‐Callerfelt, A., Jolly, M. K., Myers, S., Sharma, P. K., Jones, B., Rahman, M. A., Markos, J., Chia, C., et al. (2018) · Drugs · doi:10.1007/s40265-018-1001-8 · Cited by 93
Healy, C. M., Muñoz‐Wolf, N., Strydom, J., Faherty, L., Williams, N. C., Kenny, S., Donnelly, S. C., & Cloonan, S. M. (2021) · Respiratory Research · doi:10.1186/s12931-021-01722-y · Cited by 90
Personalized medicine for patients with COPD: where are we?
Franssen, F. M. E., Alter, P. J., Bar, N., Benedikter, B. J., Iurato, S., Maier, D., Maxheim, M., Roessler, F. K., Spruit, M. A., Vogelmeier, C. F., et al. (2019) · International Journal of COPD · doi:10.2147/copd.s175706 · Cited by 96
Self-citationÅhrman, E., Hallgren, O., Malmström, L., Hedström, U., Malmström, A., Bjermer, L., Zhou, X.-H., Westergren-Thorsson, G., & Malmström, J. (2018) · Journal of Proteomics · doi:10.1016/j.jprot.2018.02.027 · Cited by 88
Endoscopic Lung Volume Reduction: An Expert Panel Recommendation - Update 2017
Herth, F. J. F., Slebos, D., Criner, G. J., & Shah, P. L. (2017) · Respiration · doi:10.1159/000479379 · Cited by 87
Self-citationChronic obstructive pulmonary disease subpopulations and phenotyping
Segal, L. N., & Martínez, F. J. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.02.035 · Cited by 97
Endobronchial valves for severe emphysema
Hartman, J. E., Vanfleteren, L. E. G. W., van Rikxoort, E. M., Klooster, K., & Slebos, D. (2019) · European Respiratory Review · doi:10.1183/16000617.0121-2018 · Cited by 87
Sarcopenia Associated with Chronic Obstructive Pulmonary Disease
Kim, S. H., Shin, M., Shin, Y. B., & Kim, K. U. (2019) · Journal of Bone Metabolism · doi:10.11005/jbm.2019.26.2.65 · Cited by 87
Recommendations for Implementing Lung Cancer Screening with Low-Dose Computed Tomography in Europe
Veronesi, G., Baldwin, D., Henschke, C. I., Ghislandi, S., Iavicoli, S., Oudkerk, M., de Koning, H. J., Shemesh, J., Field, J. K., Zulueta, J. J., et al. (2020) · Cancers · doi:10.3390/cancers12061672 · Cited by 89
Rustam, S., Hu, Y., Mahjour, S. B., Rendeiro, A. F., Ravichandran, H., Urso, A., D’Ovidio, F., Martínez, F. J., Altorki, N. K., Richmond, B. W., et al. (2023) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202207-1384oc · Cited by 92
Phenotypes, Etiotypes, and Endotypes of Exacerbations of Chronic Obstructive Pulmonary Disease
Bhatt, S. P., Agustí, A. G. N., Bafadhel, M., Christenson, S. A., Bon, J. M., Donaldson, G. C., Sin, D. D., Wedzicha, J. A., & Martínez, F. J. (2023) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202209-1748so · Cited by 86
Self-citationEvolutionary modifications in human brain connectivity associated with schizophrenia
van den Heuvel, M. P., Scholtens, L. H., de Lange, S. C., Pijnenburg, R., Cahn, W., van Haren, N. E. M., Sommer, I. E., Bozzali, M., Koch, K., Boks, M. P., et al. (2019) · Brain · doi:10.1093/brain/awz330 · Cited by 84
Elevated circulating MMP-9 is linked to increased COPD exacerbation risk in SPIROMICS and COPDGene
Wells, J. M., Parker, M. M., Oster, R. A., Bowler, R. P., Dransfield, M. T., Bhatt, S. P., Cho, M. H., Kim, V., Curtis, J. L., Martínez, F. J., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.123614 · Cited by 85
Szmidt, M. K., Kałuża, J., Harris, H. R., Lindén, A., & Wolk, A. (2019) · European Journal of Nutrition · doi:10.1007/s00394-019-02038-w · Cited by 86
A high-risk airway mycobiome is associated with frequent exacerbation and mortality in COPD
Tiew, P. Y., Dicker, A., Keir, H. R., Poh, M. E., Pang, S. L., Aogáin, M. M., Chua, B. Q. Y., Tan, J. L., Xu, H., Koh, M. S., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.02050-2020 · Cited by 90
Gedebjerg, A., Szépligeti, S. K., Wackerhausen, L.-M. H., Horváth–Puhó, E., Dahl, R., Hansen, J. G., Sørensen, H. T., Nørgaard, M., Lange, P., & Thomsen, R. W. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30002-x · Cited by 84
IL-22 and its receptors are increased in human and experimental COPD and contribute to pathogenesis
Starkey, M. R., Plank, M. W., Casolari, P., Papi, A. A., Pavlidis, S. P., Guo, Y., Cameron, G. J. M., Haw, T. J., Tam, A., Obiedat, M., et al. (2019) · European Respiratory Journal · doi:10.1183/13993003.00174-2018 · Cited by 84
Self-citationEffects of Diaphragmatic Breathing With and Without Pursed-Lips Breathing in Subjects With COPD
Mendes, L. P. D. S., Moraes, K. S., Hoffman, M., Vieira, D. S. R., Ribeiro-Samora, G. A., Lage, S. M., Britto, R. R., & Parreira, V. F. (2018) · Respiratory Care · doi:10.4187/respcare.06319 · Cited by 98
Celli, B. R., Anderson, J. A., Cowans, N. J., Crim, C. C., Hartley, B. F., Martínez, F. J., Morris, A. N., Quasny, H., Yates, J., Vestbo, J., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202005-1854oc · Cited by 85
Self-citationPolypharmacy stewardship: a novel approach to tackle a major public health crisis
Daunt, R., Curtin, D., & O’Mahony, D. (2023) · The Lancet Healthy Longevity · doi:10.1016/s2666-7568(23)00036-3 · Cited by 82
Validation of the portable Air-Smart Spirometer
Hernández, C. R., Fernández, M. N., Pallarés-Sanmartín, A., Roibas, C. M., Domínguez, L. C., Rial, M. I. B., Cid, N. B., & Fernández‐Villar, A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0192789 · Cited by 82
Choi, J., Oh, J. Y., Lee, Y. S., Min, K. H., Hur, G. Y., Lee, S. Y., Kang, K. H., & Shim, J. J. (2018) · International Journal of COPD · doi:10.2147/copd.s156617 · Cited by 81
Environmental fungal sensitisation associates with poorer clinical outcomes in COPD
Tiew, P. Y., Ko, F. W. S., Pang, S. L., Matta, S. A., Sio, Y. Y., Poh, M. E., Lau, K. J. X., Aogáin, M. M., Jaggi, T. K., Ivan, F. X., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.00418-2020 · Cited by 83
Pulmonary Function Tests for the Generalist: A Brief Review
Dempsey, T. M., & Scanlon, P. D. (2018) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2018.04.009 · Cited by 80
Ng-Blichfeldt, J.-P., Schrik, A., Kortekaas, R. K., Noordhoek, J. A., Heijink, I. H., Hiemstra, P. S., Stolk, J. N., Königshoff, M., & Gosens, R. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.09.002 · Cited by 80
Low and High Blood Eosinophil Counts as Biomarkers in Hospitalized Acute Exacerbations of COPD
MacDonald, M., Osadnik, C. R., Bulfin, L., Hamza, K., Leong, P., Wong, A., King, P. T., & Bardin, P. G. (2019) · CHEST Journal · doi:10.1016/j.chest.2019.02.406 · Cited by 80
Sarkar, C., Zhang, B., Ni, M. Y., Kumari, S., Bauermeister, S., Gallacher, J., & Webster, C. J. (2019) · The Lancet Planetary Health · doi:10.1016/s2542-5196(19)30214-1 · Cited by 80
Clinical Implication of Phosphodiesterase-4-Inhibition
Schick, M. A., & Schlegel, N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031209 · Cited by 80
Characteristics and potential role of M2 macrophages in COPD
He, S., Xie, L., Lu, J., & Sun, S. (2017) · International Journal of COPD · doi:10.2147/copd.s147144 · Cited by 80
Xie, Z., Ossip, D. J., Rahman, I., & Li, D. (2019) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntz234 · Cited by 80
Su, Z., Guan, W., Li, S., Ding, M., Chen, Y., Jiang, M., Chen, X., Zhong, C., Tang, C., & Zhong, N. (2018) · International Journal of COPD · doi:10.2147/copd.s172639 · Cited by 79
Kwan, H. Y., Maddocks, M. M., Nolan, C. M., Jones, S. E., Patel, S., Barker, R. E., Kon, S. S. C., Polkey, M. I., Cullinan, P., & Man, W. D. (2019) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12463 · Cited by 80
Higham, A., Bostock, D., Booth, G. C., Dungwa, J. V., & Singh, D. (2018) · International Journal of COPD · doi:10.2147/copd.s157728 · Cited by 78
Self-citationBak, S. H., Kwon, S. O., Han, S., & Kim, W. J. (2019) · Respiratory Research · doi:10.1186/s12931-019-1191-y · Cited by 81
Abdallah, S. J., Wilkinson-Maitland, C. A., Saad, N., Li, P. Z., Smith, B. M., Bourbeau, J., & Jensen, D. (2017) · European Respiratory Journal · doi:10.1183/13993003.01235-2017 · Cited by 78
Self-citationSmall airways disease: time for a revisit?
Stockley, J. A., Cooper, B. G., Stockley, R. A., & Sapey, E. (2017) · International Journal of COPD · doi:10.2147/copd.s138540 · Cited by 77
Self-citationGao, Y., Liang, M., Li, M., Fang, X., Liu, J., Lai, Y., Chen, J., Yao, W., Feng, X., Hu, L., et al. (2018) · Inflammation Research · doi:10.1007/s00011-018-1145-8 · Cited by 75
Wada, H., Ikeda, A., Maruyama, K., Yamagishi, K., Barnes, P. J., Tanigawa, T., Tamakoshi, A., & Iso, H. (2021) · Scientific Reports · doi:10.1038/s41598-020-79860-4 · Cited by 83
Self-citationPeng, J., Chen, C., Ζhou, M., Xie, X., Zhou, Y., & Luo, C. (2020) · Scientific Reports · doi:10.1038/s41598-020-60042-1 · Cited by 76
Haw, T. J., Starkey, M. R., Pavlidis, S. P., Fricker, M., Arthurs, A. L., Nair, P. M., Liu, G., Hanish, I., Kim, R., Foster, P. S., et al. (2017) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00154.2017 · Cited by 77
Defining the role of neutrophil-to-lymphocyte ratio in COPD: a systematic literature review
Pascual-González, Y., López‐Sánchez, M., Dorca, J., & Santos, S. (2018) · International Journal of COPD · doi:10.2147/copd.s178068 · Cited by 75
Bhattarai, B., Walpola, R. L., Mey, A., Anoopkumar‐Dukie, S., & Khan, S. A. (2020) · Respiratory Care · doi:10.4187/respcare.07355 · Cited by 79
Oxidative Stress Promotes Corticosteroid Insensitivity in Asthma and COPD
Lewis, B. W., Ford, M. L., Rogers, L. K., & Britt, R. D. (2021) · Antioxidants · doi:10.3390/antiox10091335 · Cited by 78
What can we learn about COPD from impulse oscillometry?
Lipworth, B. J., & Jabbal, S. (2018) · Respiratory Medicine · doi:10.1016/j.rmed.2018.05.004 · Cited by 75
Lung Function Abnormalities in Smokers with Ischemic Heart Disease
Franssen, F. M. E., Soriano, J. B., Roche, N., Bloomfield, P. H., Brusselle, G., Fabbri, L. M., Rio, F. G., Kearney, M. T., Kwon, N., Lundbäck, B., et al. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201512-2480oc · Cited by 77
Self-citationGuo, B., Wang, Y., Pei, L., Yu, Y., Liu, F., Zhang, D., Wang, X., Su, Y., Zhang, D., Zhang, B., et al. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2020.143869 · Cited by 74
The etiologic origins for chronic obstructive pulmonary disease
Huang, X., Xi, M., Deng, L., Fu, A., Pu, E., Tang, T., & Kong, X. (2019) · International Journal of COPD · doi:10.2147/copd.s203215 · Cited by 79
He, S., Chen, D., Hu, M., Zhang, L., Liu, C., Traini, D., Grau, G. E., Zeng, Z., Lu, J., Zhou, G., et al. (2019) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2019.03.010 · Cited by 76
Antiviral immunity is impaired in COPD patients with frequent exacerbations
Singanayagam, A., Loo, S.-L., Calderazzo, M. A., Finney, L., Torralbo, M.-B. T., Bakhsoliani, E., Girkin, J. L. N., Veerati, P. C., Pathinayake, P. S., Nichol, K., et al. (2019) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00253.2019 · Cited by 79
Role of Lung Microbiome in Innate Immune Response Associated With Chronic Lung Diseases
Paudel, K. R., Dharwal, V., Patel, V. K., Galvão, I., Wadhwa, R., Malyla, V., Shen, S., Budden, K. F., Hansbro, N. G., Vaughan, A., et al. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00554 · Cited by 75
Viegas, J., Esteves, A. F., Cardoso, E. M., Arosa, F. A., Vitale, M., & Taborda‐Barata, L. (2019) · Frontiers in Public Health · doi:10.3389/fpubh.2019.00128 · Cited by 77
Opsonic Phagocytosis in Chronic Obstructive Pulmonary Disease Is Enhanced by Nrf2 Agonists
Bewley, M. A., Budd, R. C., Ryan, E. M., Cole, J., Collini, P., Marshall, J. L., Kolsum, U., Beech, G., Emes, R. D., Tcherniaeva, I., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201705-0903oc · Cited by 73
Self-citationKaasgaard, M., Rasmussen, D. B., Andreasson, K. H., Hilberg, O., Løkke, A., Vuust, P., & Bødtger, U. C. S. (2021) · European Respiratory Journal · doi:10.1183/13993003.01142-2021 · Cited by 72
Charususin, N., Dacha, S., Gosselink, R., Decramer, M., von Leupoldt, A., Reijnders, T., Louvaris, Z., & Langer, D. (2017) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2018.1398084 · Cited by 75
Self-citationLoeckx, M., Rabinovich, R., Demeyer, H., Louvaris, Z., Tanner, R., Rubio, N., Frei, A. L., de Jong, C., Gimeno‐Santos, E., Rodrigues, F. M. M., et al. (2018) · JMIR mhealth and uhealth · doi:10.2196/mhealth.9774 · Cited by 74
Prognostic significance of chronic respiratory symptoms in individuals with normal spirometry
Çolak, Y., Nordestgaard, B. G., Vestbo, J., Lange, P., & Afzal, S. (2019) · European Respiratory Journal · doi:10.1183/13993003.00734-2019 · Cited by 74
Self-citationO'Dwyer, S., Greene, G., MacHale, E., Cushen, B., Sulaiman, I., Boland, F., Bosnic-Anticevich, S. Z., Mokoka, M., Reilly, R. B., Taylor, T. E., et al. (2019) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2019.09.008 · Cited by 71
The AGE-RAGE Axis and RAGE Genetics in Chronic Obstructive Pulmonary Disease
Sharma, A., Kaur, S., Sarkar, M. S., Sarin, B., & Changotra, H. (2020) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-020-08815-4 · Cited by 71
Toward precision medicine in COPD: phenotypes, endotypes, biomarkers, and treatable traits
Xie, C. H., Wang, K., Yang, K., Zhong, Y., Gul, A., Luo, W., Yalikun, M., He, J., Chen, W., Xu, W., et al. (2025) · Respiratory Research · doi:10.1186/s12931-025-03356-w · Cited by 84
Pizzini, A., Filipiak, W., Wille, J., Ager, C., Wiesenhofer, H., Kubinec, R., Blaško, J., Tschurtschenthaler, C., Mayhew, C. A., Weiß, G., et al. (2018) · Journal of Breath Research · doi:10.1088/1752-7163/aaa4c5 · Cited by 71
The past, present and future of pulmonary rehabilitation
Troosters, T., Blondeel, A., Janssens, W., & Demeyer, H. (2019) · Respirology · doi:10.1111/resp.13517 · Cited by 76
Extracellular Release of Mitochondrial DNA: Triggered by Cigarette Smoke and Detected in COPD
Giordano, L., Gregory, A. D., Pérez-Verdaguer, M., Ware, S. A., Harvey, H., DeVallance, E., Brzóska, T., Sundd, P., Zhang, Y., Sciurba, F. C., et al. (2022) · Cells · doi:10.3390/cells11030369 · Cited by 69
COPD and acute myocardial infarction
Goedemans, L., Bax, J. J., & Delgado, V. (2020) · European Respiratory Review · doi:10.1183/16000617.0139-2019 · Cited by 69
Kałuża, J., Harris, H. R., Lindén, A., & Wolk, A. (2018) · International Journal of Epidemiology · doi:10.1093/ije/dyy178 · Cited by 68
Wang, C., Chen, X., Du, L., Zhan, Q., Yang, T., & Fang, Z. (2019) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2019.105267 · Cited by 68
Chen, T., Zhong, F., Yao, C., Chen, J., Xiang, Y., Dong, J., Yan, Z., & Ma, Y. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/1536534 · Cited by 67
Liao, Q.-Q., Mo, Y.-J., Zhu, K., Gao, F., Huang, B., Chen, P., Jing, F.-T., Jiang, X., Xu, H.-Z., Tang, Y.-F., et al. (2024) · International Journal of COPD · doi:10.2147/copd.s447519 · Cited by 67
Update on non-typeable Haemophilus influenzae- mediated disease and vaccine development
Jalalvand, F., & Riesbeck, K. (2018) · Expert Review of Vaccines · doi:10.1080/14760584.2018.1484286 · Cited by 67
Neuromuscular electrostimulation for adults with chronic obstructive pulmonary disease
Hill, K., Cavalheri, V., Mathur, S., Roig, M., Janaudis‐Ferreira, T., Robles, P., Dolmage, T. E., & Goldstein, R. S. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010821.pub2 · Cited by 67
Wu, A. C., Kiley, J. P., Noel, P. J., Amur, S., Burchard, E. G., Clancy, J. P., Galanter, J., Inada, M., Jones, T. K., Kropski, J. A., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201810-1895st · Cited by 69
Self-citationRossi, A., Petanjek, B. B., Chilosi, M., Cosío, B. G., Fležar, M., Koulouris, N. G., Marín, J. M., Miculinić, N., Polese, G., Samaržija, M., et al. (2017) · International Journal of COPD · doi:10.2147/copd.s132236 · Cited by 69
Armitage, J. D., Tan, D. B. A., Troedson, R., Young, P., Lam, K.-V., Shaw, K., Sturm, M., Weiss, D. J., & Moodley, Y. P. (2018) · European Respiratory Journal · doi:10.1183/13993003.02369-2017 · Cited by 66
Management of the COPD Patient with Comorbidities: An Experts Recommendation Document
Iglesias, J. R., Díez‐Manglano, J., Garcı́a, F. L., Peromingo, J. A. D., Almagro, P., & Aguilar, J. M. V. (2020) · International Journal of COPD · doi:10.2147/copd.s242009 · Cited by 74
Frailty and clinical benefits with lung transplantation
Rozenberg, D., Mathur, S., Wickerson, L. M., Chowdhury, N., & Singer, L. G. (2018) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2018.06.005 · Cited by 67
Effects of Home-Based Breathing Exercises in Subjects With COPD
Lu, Y., Li, P., Li, N., Wang, Z., Li, J., Liu, X., & Wu, W. (2019) · Respiratory Care · doi:10.4187/respcare.07121 · Cited by 73
Clinical presentation and comorbidities of obstructive sleep apnea-COPD overlap syndrome
Adler, D., Bailly, S., Benmerad, M., Joyeux‐Faure, M., Jullian‐Desayes, I., Soccal, P. M., Janssens, J.-P., Sapène, M., Grillet, Y., Stach, B., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0235331 · Cited by 66
Metadata
- Authors
- Vogelmeier, C. F., Criner, G. J., Martinez, F. J., Anzueto, A., Barnes, P. J., Bourbeau, J., Celli, B. R., Chen, R., Decramer, M., Fabbri, L. M., Frith, P., Halpin, D. M. G., López Varela, M. V., Nishimura, M., Roche, N., Rodriguez-Roisin, R., Sin, D. D., Singh, D., Stockley, R., Vestbo, J., Wedzicha, J. A., & Agustí, A.
- Affiliations
- Philipps University of Marburg (DE)
- Temple University (US)
- New York-Presbyterian Hospital, Weill Cornell Medical Center, New York, New York
- The University of Texas at San Antonio Health Science Center (US)
- Imperial College London (GB)
- McGill University Health Centre (CA)
- Brigham and Women’s Hospital, Boston, Massachusetts
- First Affiliated Hospital of Guangzhou Medical University (CN)
- KU Leuven (BE)
- University of Modena and Reggio Emilia (IT)
- Flinders University (AU)
- Royal Devon and Exeter Hospital (GB)
- Universidad de la República, Hospital Maciel, Montevideo, Uruguay
- Hokkaido University (JP)
- Hôpital Cochin (Assistance Publique–Hôpitaux de Paris), University Paris Descartes, Paris, France
- Thorax Institute, Hospital Clinic Universitat de Barcelona, Barcelona, Spain
- University of British Columbia (CA)
- University Hospital, Birmingham, United Kingdom; and
- University of Manchester (GB)
- Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (ES)
- Corresponding author
- Vogelmeier, Claus F.
- ORCID
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-03-01
- Volume
- 195
- Issue
- 5
- Pages
- 557-582
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2583265473
- Cited by
- 3,187
- References
- 305
- Citations by year
- 2026: 118 · 2025: 162 · 2024: 247 · 2023: 307 · 2022: 415 · 2021: 441 · 2020: 449 · 2019: 436 · 2018: 428 · 2017: 173
- FWCI
- 336.54
- Type
- journal article
- Language
- en
- Open access
- green
- lirias.kuleuven.be
- Locations
- American Journal of Respiratory and Critical Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Lirias (KU Leuven) (submittedVersion, other-oa)
- Royal Devon and Exeter Research Repository (Royal Devon and Exeter) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion)
- Funders
- National Institute for Health and Care Research (NF-SI-0510-10270, NF-SI-0513-10077, NF-SI-0611-10148)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
- Keywords
- chronic obstructive pulmonary disease, GOLD 2017, COPD diagnosis, COPD management, COPD prevention, exacerbations, non-pharmacological treatment, comorbidities, spirometry, symptom assessment
- MeSH terms
- Bronchodilator Agents, Humans, Risk Factors, Spirometry, Global Health, Pulmonary Disease, Chronic Obstructive, Internationality
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
